The complexities of correlating LOX family expression and tumour staging are typified in prostate cancer, where high LOX expression has been correlated with advanced tumour stage; however, low LOX expression was associated with decreased overall survival [128]. The gene discussed is LOX; the disease is Familial prostate cancer.